Clinical Trials Directory

Trials / Recruiting

RecruitingNCT01510067

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Status
Recruiting
Phase
Study type
Observational
Enrollment
700 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).

Detailed description

The database has yielded valuable information and clinical insights into the pathophysiology, disease processes, treatments and quality of life associated with CLE. The CLE database incorporates the CLASI (Cutaneous Lupus Activity and Severity Index), a validated outcome measure of disease responsiveness in patients and other assessment tools, surveys and patient information to help validate the clinical course and quality of life of patients with CLE (cutaneous lupus erythematosus). The CLE database has led to publication of significant studies on lupus and its clinical course, the effect of lupus on Quality of Life (QoL), including the effect of photosensitivity on QoL, and the effect of first line medications. The CLE database is an ongoing resource that enables clinicians to evaluate the evolving clinical changes, treatment modalities and patient response to a challenging disease.

Conditions

Timeline

Start date
2006-12-01
Primary completion
2030-01-02
Completion
2030-01-02
First posted
2012-01-13
Last updated
2026-03-30

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01510067. Inclusion in this directory is not an endorsement.